Raymond James & Associates Davita Inc. Transaction History

Raymond James & Associates

$150 Billion
Q2 2024

A detailed history of Raymond James & Associates transactions in Davita Inc. stock. As of the latest transaction made, Raymond James & Associates holds 16,178 shares of DVA stock, worth $2.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,178

Previous 34,608 53.25%

Holding current value

$2.41 Million

Previous $4.78 Million 53.09%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$126.11 - $147.14 $2.32 Million - $2.71 Million	-18,430 Reduced 53.25%	16,178 $2.24 Million
Q1 2024 Apr 22, 2024	BUY	$103.89 - $139.21 $24,102 - $32,296	232 Added 0.67%	34,608 $4.78 Million
Q4 2023 Jan 16, 2024	BUY	$73.2 - $108.8 $1.45 Million - $2.15 Million	19,759 Added 135.18%	34,376 $3.6 Million
Q3 2023 Oct 24, 2023	SELL	$94.53 - $112.68 $69,952 - $83,383	-740 Reduced 4.82%	14,617 $1.38 Million
Q2 2023 Jul 25, 2023	SELL	$81.58 - $100.93 $206,968 - $256,059	-2,537 Reduced 14.18%	15,357 $1.54 Million
Q1 2023 Apr 14, 2023	SELL	$74.68 - $85.82 $107,987 - $124,095	-1,446 Reduced 7.48%	17,894 $1.45 Million
Q4 2022 Feb 08, 2023	SELL	$65.42 - $99.31 $163,288 - $247,877	-2,496 Reduced 11.43%	19,340 $1.44 Million
Q3 2022 Oct 25, 2022	BUY	$80.24 - $95.27 $223,227 - $265,041	2,782 Added 14.6%	21,836 $1.81 Million
Q2 2022 Aug 12, 2022	SELL	$76.05 - $123.38 $273,551 - $443,797	-3,597 Reduced 15.88%	19,054 $1.52 Million
Q1 2022 May 11, 2022	BUY	$108.37 - $120.0 $93,740 - $103,800	865 Added 3.97%	22,651 $2.56 Million
Q4 2021 Feb 08, 2022	SELL	$94.5 - $116.95 $2.95 Million - $3.65 Million	-31,232 Reduced 58.91%	21,786 $2.48 Million
Q3 2021 Nov 02, 2021	BUY	$116.26 - $133.78 $19,996 - $23,010	172 Added 0.33%	53,018 $6.16 Million
Q2 2021 Aug 11, 2021	SELL	$105.44 - $127.98 $919,858 - $1.12 Million	-8,724 Reduced 14.17%	52,846 $6.36 Million
Q1 2021 May 14, 2021	SELL	$99.98 - $123.89 $1.96 Million - $2.43 Million	-19,638 Reduced 24.18%	61,570 $6.64 Million
Q4 2020 Feb 12, 2021	BUY	$82.82 - $117.4 $1.35 Million - $1.91 Million	16,283 Added 25.08%	81,208 $9.53 Million
Q3 2020 Nov 04, 2020	BUY	$79.57 - $91.84 $25,303 - $29,205	318 Added 0.49%	64,925 $5.56 Million
Q2 2020 Jul 28, 2020	SELL	$65.52 - $88.28 $1.08 Million - $1.46 Million	-16,498 Reduced 20.34%	64,607 $5.11 Million
Q1 2020 Apr 21, 2020	SELL	$64.99 - $88.5 $1.87 Million - $2.54 Million	-28,756 Reduced 26.17%	81,105 $6.17 Million
Q4 2019 Feb 12, 2020	SELL	$54.2 - $75.03 $1.51 Million - $2.09 Million	-27,875 Reduced 20.24%	109,861 $8.24 Million
Q3 2019 Nov 07, 2019	SELL	$52.55 - $63.28 $941,433 - $1.13 Million	-17,915 Reduced 11.51%	137,736 $7.86 Million
Q2 2019 Aug 06, 2019	BUY	$43.42 - $57.79 $38,253 - $50,912	881 Added 0.57%	155,651 $8.76 Million
Q1 2019 May 06, 2019	BUY	$49.95 - $59.21 $677,371 - $802,946	13,561 Added 9.6%	154,770 $8.4 Million
Q4 2018 Feb 11, 2019	BUY	$48.73 - $76.08 $2.65 Million - $4.14 Million	54,435 Added 62.73%	141,209 $7.27 Million
Q3 2018 Nov 14, 2018	SELL	$66.51 - $74.55 $1.28 Million - $1.44 Million	-19,298 Reduced 18.19%	86,774 $6.22 Million
Q2 2018 Aug 14, 2018	BUY	$62.77 - $73.47 $730,454 - $854,970	11,637 Added 12.32%	106,072 $7.37 Million
Q1 2018 May 14, 2018	SELL	$65.0 - $80.03 $2 Million - $2.46 Million	-30,786 Reduced 24.59%	94,435 $6.23 Million
Q4 2017 Feb 14, 2018	SELL	$53.89 - $72.36 $2.27 Million - $3.04 Million	-42,052 Reduced 25.14%	125,221 $9.05 Million
Q3 2017 Nov 13, 2017	BUY	$56.13 - $64.78 $974,809 - $1.13 Million	17,367 Added 11.59%	167,273 $9.93 Million
Q2 2017 Aug 14, 2017	BUY	N/A	149,906	149,906 $9.71 Million

Others Institutions Holding DVA

# of Institutions

620

Shares Held

76.1M

Call Options Held

1.16M

Put Options Held

760K

View Full List

About DAVITA INC.

Ticker DVA
Exchange NYSE
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 91,300,000
Market Cap $13.6B
Description
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...

More about DVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Davita Inc. Transaction History